4X2T
X-ray crystal structure of the orally available aminopeptidase inhibitor, Tosedostat, bound to the M17 Leucyl Aminopeptidase from P. falciparum
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
| Synchrotron site | Australian Synchrotron |
| Beamline | MX2 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2013-12-15 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 1.12819 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 173.715, 176.698, 223.977 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 48.748 - 2.729 |
| R-factor | 0.2225 |
| Rwork | 0.220 |
| R-free | 0.27370 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3kqx |
| RMSD bond length | 0.008 |
| RMSD bond angle | 1.290 |
| Data scaling software | Aimless (0.1.29) |
| Phasing software | PHASER |
| Refinement software | PHENIX ((phenix.refine: 1.8.4_1496)) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 48.750 | 48.750 | 2.780 |
| High resolution limit [Å] | 2.729 | 14.950 | 2.730 |
| Rmerge | 0.052 | 0.465 | |
| Rpim | 0.080 | 0.033 | 0.287 |
| Total number of observations | 664861 | 4017 | 26638 |
| Number of reflections | 181046 | ||
| <I/σ(I)> | 7.7 | 13.1 | 2.5 |
| Completeness [%] | 99.1 | 94.4 | 86.5 |
| Redundancy | 3.7 | 3.5 | 3.4 |
| CC(1/2) | 0.990 | 0.997 | 0.835 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 8.6 | 298 | 35% (v/v) PEG 400, 0.1 M Tris pH 8.6, 0.2 M Li2SO4 |






